Stockhub

AVAX Technologies, Inc.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

19 August 2022

  • curprev 16:5316:53, 19 August 2022‎ 95.149.241.133 talk‎ 708 bytes +708‎ Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == AVAX Technologies, Inc., a development stage biopharmaceutical company, develops autologous cell vaccine technologies for the treatment of cancer. The company's product candidates that have completed phase II clinical trials include M-VAX for the treatment of melanoma and O-VAX for the treatment for ovarian cancer. It also develops LungVax for the treatment of non-small cell lung cancer. The company was formerly known as Wa..." Tag: Visual edit: Switched
Retrieved from ‘https://stockhub.co/research/AVAX_Technologies,_Inc.’